|
FR901228A
(fr)
|
1943-01-16 |
1945-07-20 |
Deutsche Edelstahlwerke Ag |
Système d'aimant à entrefer annulaire
|
|
US4754065A
(en)
|
1984-12-18 |
1988-06-28 |
Cetus Corporation |
Precursor to nucleic acid probe
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
GB8611832D0
(en)
|
1986-05-15 |
1986-06-25 |
Holland I B |
Polypeptide
|
|
US5037743A
(en)
|
1988-08-05 |
1991-08-06 |
Zymogenetics, Inc. |
BAR1 secretion signal
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US6106834A
(en)
|
1993-06-02 |
2000-08-22 |
Research Corporation Technologies, Inc. |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US20030036654A1
(en)
|
1994-08-18 |
2003-02-20 |
Holt Dennis A. |
Synthetic multimerizing agents
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US6011138A
(en)
|
1997-02-20 |
2000-01-04 |
Idec Pharmaceuticals Corporation |
Gamma-1 anti-human CD23 monoclonal antibodies
|
|
KR20030032922A
(ko)
|
2000-02-24 |
2003-04-26 |
싸이트 테라피스 인코포레이티드 |
세포의 동시 자극 및 농축
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
|
CN100574803C
(zh)
|
2001-01-31 |
2009-12-30 |
拜奥根Idec公司 |
免疫调节抗体在治疗肿瘤性疾病中的用途
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
TW200521231A
(en)
|
2003-09-18 |
2005-07-01 |
Novartis Ag |
Therapeutic binding molecules
|
|
PT1731605E
(pt)
|
2004-03-31 |
2010-04-14 |
Int Inst Cancer Immunology Inc |
Péptidos antigénicos de cancro derivados de wt1
|
|
WO2007137300A2
(en)
|
2006-05-23 |
2007-11-29 |
Bellicum Pharmaceuticals, Inc. |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
|
CA3255551A1
(en)
|
2010-03-26 |
2025-04-15 |
Memorial Sloan-Kettering Cancer Center |
MUC16 ANTIBODIES AND METHODS OF USE
|
|
US8557961B2
(en)
|
2010-04-02 |
2013-10-15 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
AU2012209103B2
(en)
|
2011-01-26 |
2015-12-03 |
Takeda Pharmaceutical Company Limited |
Methods and compositions for the synthesis of multimerizing agents
|
|
US20130080084A1
(en)
|
2011-09-28 |
2013-03-28 |
John P. Miller |
Pressure transmitter with diagnostics
|
|
CA2861003C
(en)
|
2012-01-13 |
2023-03-28 |
Julius-Maximilians-Universitat Wurzburg |
Dual antigen-induced bipartite functional complementation
|
|
JP6355563B2
(ja)
|
2012-02-27 |
2018-07-11 |
アムニクス オペレーティング インコーポレイテッド |
Ｘｔｅｎ共役組成物およびそれを製造する方法
|
|
GB201206559D0
(en)
|
2012-04-13 |
2012-05-30 |
Ucl Business Plc |
Polypeptide
|
|
DK2956175T3
(da)
|
2013-02-15 |
2017-11-27 |
Univ California |
Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf
|
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
US11077144B2
(en)
|
2013-05-13 |
2021-08-03 |
Cellectis |
CD19 specific chimeric antigen receptor and uses thereof
|
|
EP3925618A1
(en)
|
2013-07-29 |
2021-12-22 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
CN105940102B
(zh)
|
2013-08-26 |
2020-02-18 |
海瑞克·亚柏坎 |
抗cd30嵌合抗原受体及其用途
|
|
EP3087101B1
(en)
|
2013-12-20 |
2024-06-05 |
Novartis AG |
Regulatable chimeric antigen receptor
|
|
US9562073B2
(en)
|
2014-01-31 |
2017-02-07 |
Cytomx Therapeutics, Inc. |
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
US20160152725A1
(en)
|
2014-02-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Antigen-binding proteins specific for hla-a2-restricted wilms tumor 1 peptide
|
|
BR112017001183A2
(pt)
|
2014-07-21 |
2017-11-28 |
Novartis Ag |
tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado
|
|
TWI719942B
(zh)
|
2014-07-21 |
2021-03-01 |
瑞士商諾華公司 |
使用ｃｄ３３嵌合抗原受體治療癌症
|
|
GB201413335D0
(en)
|
2014-07-28 |
2014-09-10 |
Azotic Technologies Ltd |
Agricultural methods
|
|
WO2016016341A1
(en)
|
2014-07-29 |
2016-02-04 |
Cellectis |
EGFRvIII SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY
|
|
ES2818103T3
(es)
|
2015-01-16 |
2021-04-09 |
Juno Therapeutics Inc |
Anticuerpos y receptores de antígenos quiméricos específicos para ROR1
|
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
|
BR112017013981A2
(pt)
|
2015-01-26 |
2018-01-02 |
Cellectis |
receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer
|
|
SG11201707538XA
(en)
|
2015-03-17 |
2017-10-30 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
US10294304B2
(en)
|
2015-04-13 |
2019-05-21 |
Pfizer Inc. |
Chimeric antigen receptors targeting B-cell maturation antigen
|
|
TW201702272A
(zh)
|
2015-05-22 |
2017-01-16 |
美國紀念斯隆 凱特琳癌症中心 |
Ｐｒａｍｅ肽專一性類ｔ細胞受體抗體
|
|
GB201601073D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies
|
|
WO2017025323A1
(en)
|
2015-08-11 |
2017-02-16 |
Cellectis |
Cells for immunotherapy engineered for targeting cd38 antigen and for cd38 gene inactivation
|
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
MX2018004503A
(es)
|
2015-10-15 |
2019-04-15 |
Us Health |
Receptores de antigeno quimerico anti-cd30.
|
|
TWI755547B
(zh)
|
2016-01-21 |
2022-02-21 |
美商輝瑞股份有限公司 |
靶向表皮生長因子受體變異體iii之嵌合型抗原受體
|
|
JP7015244B2
(ja)
*
|
2016-03-22 |
2022-02-02 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
プロテアーゼ活性化ｔ細胞二重特異性分子
|
|
IL262061B2
(en)
|
2016-04-01 |
2023-03-01 |
Amgen Inc |
Chimeric flt-3 receptors and methods of using them
|
|
BR112018070948A2
(pt)
|
2016-04-13 |
2019-01-29 |
Orimabs Ltd. |
anticorpos anti-psma e utilização dos mesmos
|
|
ES2979068T3
(es)
|
2016-07-08 |
2024-09-24 |
Crage Medical Co Ltd |
Anticuerpos para anti-claudina 18A2 y utilización de los mismos
|
|
WO2018072025A1
(en)
|
2016-10-19 |
2018-04-26 |
The Governing Council Of The University Of Toronto |
Cd133-binding agents and uses thereof
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
TWI785009B
(zh)
|
2017-02-14 |
2022-12-01 |
美商凱特製藥公司 |
Ｃｄ７０結合分子及使用彼之方法
|
|
SG10202108528QA
(en)
|
2017-06-02 |
2021-09-29 |
Pfizer |
Chimeric antigen receptors targeting flt3
|
|
KR20230008269A
(ko)
|
2017-08-07 |
2023-01-13 |
엔비이-테라퓨틱스 아게 |
생체 내 내성이 높은 항체 약물 결합체
|
|
CN112020518A
(zh)
|
2018-02-01 |
2020-12-01 |
辉瑞公司 |
靶向cd70的嵌合抗原受体
|
|
CN116836297A
(zh)
|
2018-04-12 |
2023-10-03 |
上海赛比曼生物科技有限公司 |
靶向bcma的嵌合抗原受体及其制法和应用
|
|
WO2019222275A2
(en)
*
|
2018-05-14 |
2019-11-21 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using inducible fusion proteins
|
|
WO2019220109A1
(en)
*
|
2018-05-15 |
2019-11-21 |
Autolus Limited |
Chimeric antigen receptor
|
|
CA3100349A1
(en)
*
|
2018-05-17 |
2019-11-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Receptor inhibition by phosphatase recruitment
|
|
US11319380B2
(en)
*
|
2018-06-04 |
2022-05-03 |
Precigen, Inc. |
MUC16 specific chimeric antigen receptors and uses thereof
|
|
US20210269501A1
(en)
|
2018-06-25 |
2021-09-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of nkg2d chimeric antigen receptor t cells for controlling triple-negative breast cancer
|
|
WO2020010284A1
(en)
|
2018-07-04 |
2020-01-09 |
Cytoimmune Therapeutics, LLC |
Compositions and methods for immunotherapy targeting flt3, pd-1, and/or pd-l1
|
|
US12036242B2
(en)
|
2018-07-05 |
2024-07-16 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CAR T cells that target B-cell antigens
|
|
BR112021001338A2
(pt)
|
2018-07-26 |
2021-05-04 |
TCR2 Therapeutics Inc. |
composições e métodos para reprogramação de tcr usando proteínas de fusão específicas para o alvo
|
|
EP3877416A4
(en)
|
2018-10-30 |
2022-07-27 |
Magenta Therapeutics, Inc. |
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
|
|
WO2020095249A1
(en)
|
2018-11-07 |
2020-05-14 |
Crispr Therapeutics Ag |
Anti-liv1 immune cell cancer therapy
|
|
CN109468284A
(zh)
|
2018-11-30 |
2019-03-15 |
北京美康基免生物科技有限公司 |
一种基于cd19和psma的双重嵌合抗原受体基因修饰的免疫细胞及其应用
|
|
AU2019397033B2
(en)
|
2018-12-12 |
2023-06-29 |
Kite Pharma, Inc. |
Chimeric antigen receptors and CAR-T cells and methods of use
|
|
CN109680002A
(zh)
|
2019-01-09 |
2019-04-26 |
上海怡豪生物科技有限公司 |
联合msln单链抗体和ccl19杀伤胃癌细胞的car载体及其构建方法和应用
|
|
CN109628492A
(zh)
|
2019-01-09 |
2019-04-16 |
上海怡豪生物科技有限公司 |
联合MSLN单链抗体和PD-1mAb杀伤胃癌细胞的CAR载体及其构建方法和应用
|
|
SMT202400408T1
(it)
|
2019-01-16 |
2024-11-15 |
Caribou Biosciences Inc |
Anticorpo umanizzato bcma e cellule bcma-car-t
|
|
US11738050B2
(en)
|
2019-02-01 |
2023-08-29 |
Regents Of The University Of Minnesota |
Compounds binding to fibroblast activation protein alpha
|
|
PH12021551720A1
(en)
|
2019-03-01 |
2022-03-28 |
Allogene Therapeutics Inc |
Dll3 targeting chimeric antigen receptors and binding agents
|
|
WO2020186204A1
(en)
|
2019-03-13 |
2020-09-17 |
Ulmert Hans David Staffan |
Prame binding molecules and uses thereof
|
|
EP3969035A4
(en)
|
2019-05-14 |
2023-06-21 |
Werewolf Therapeutics, Inc. |
SEPARATION UNITS AND METHODS AND THEIR USE
|
|
JP2022535527A
(ja)
*
|
2019-06-04 |
2022-08-09 |
マジェンタ セラピューティクス インコーポレイテッド |
自己免疫疾患を治療するための方法および組成物
|
|
KR102773187B1
(ko)
|
2019-07-12 |
2025-02-27 |
퓨쳐진 바이오파머쓰티컬 (베이징) 코., 엘티디. |
Cldn18.2 항체 및 이의 용도
|
|
CN111363046A
(zh)
|
2020-03-11 |
2020-07-03 |
深圳宾德生物技术有限公司 |
靶向nkg2d的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
AU2021312871A1
(en)
|
2020-07-21 |
2023-02-09 |
Allogene Therapeutics, Inc. |
Chimeric antigen receptors with enhanced signaling and activities and uses thereof
|
|
WO2022040088A2
(en)
*
|
2020-08-21 |
2022-02-24 |
Synthekine, Inc. |
Cd45 binding molecules and methods of use
|